Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aim of World Hepatitis Day is to increase awareness, promote discussion, celebrate successes and make steps towards better diagnosis, treatment and prevention of viral hepatitis infections.

World Hepatitis Day banner

Engaging youth in health and research in rural Cambodia: a qualitative study.

Journal article

Ean M. et al, (2026), Global health action, 19

Cephalosporins are potent SARS-CoV-2 main protease inhibitors

Journal article

Muntean D-G. et al, (2026), European Journal of Medicinal Chemistry, 316, 118995 - 118995

Global inequities in hepatitis B and C genomic surveillance revealed through an interactive data integration dashboard

Journal article

Tshiabuila D. et al, (2026), Public Health, 257, 106338 - 106338

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment

Journal article

Donovan J. et al, (2026), Journal of Infection, 93, 106796 - 106796

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection

Journal article

Preechanukul A. et al, (2026), Gut, 75, 1397 - 1410

Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis

Journal article

Fadilah I. et al, (2026), The Lancet Regional Health - Western Pacific, 72, 101908 - 101908

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?

Journal article

Matthews PC. et al, (2026), The Lancet Gastroenterology & Hepatology, 11, 542 - 543

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria.

Journal article

Wattanakul T. et al, (2026), CPT: pharmacometrics & systems pharmacology, 15

Load More